Creative Diagnostics, a reagent supplier and developer focused on biologics quality control, has announced the launch of its new Viral Nucleic Acid Residue Assay Kits (qPCR) to ensure the purity and ...
Diagnostics, Inc. (NASDAQ:CODX – Free Report) in the third quarter, Holdings Channel reports. The fund bought 44,124 shares of the company’s stock, valued at approximately $55,000. Co-Diagnostics ...